Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Omnicare Plans Role In Medicare Rx; NeighborCare Bid Is One Step

  • News

Executive Summary

Omnicare's $1.5 bil. bid for the institutional pharmacy provider NeighborCare would increase the company's drug purchasing power as it plans its role in the Medicare prescription drug benefit

You may also be interested in...



Omnicare Bulks Up And Branches Out With NeighborCare, RxCrossroads Deals

Omnicare will broaden its long-term care pharmacy practice and gain a specialty pharmaceutical distribution division through the acquisitions of NeighborCare and RxCrossroads in deals valued at a combined $2 bil

Omnicare Bulks Up And Branches Out With NeighborCare, RxCrossroads Deals

Omnicare will broaden its long-term care pharmacy practice and gain a specialty pharmaceutical distribution division through the acquisitions of NeighborCare and RxCrossroads in deals valued at a combined $2 bil

Medco Expects To Break Even On Medicare Card In 2004

Medco said it expects to cover its start up costs for the Medicare-endorsed discount card program in 2004 - setting up for a profit contribution in 2005

Table

View full table

Tags:
Latest Headlines

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’

Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116

Woodcock Takes On Rare Disease Challenges In Retirement, Keeps FDA, Industry At Arm’s Length

See All
UsernamePublicRestriction

Register

PS044077

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By